Background: Cyclophosphamide (CP) is a distinguished anticancer and immune subduing
medicament but it has neurotoxicity as a limitation. Objective: The primary objective of this …

Pharmacologic treatment for functional illnesses involves mostly the off-label use of
medications. To date, most of the published studies include generally small randomized …

Neuroleptic malignant syndrome (NMS) is a potentially fatal diagnosis composed of
hyperpyrexia, muscle rigidity, altered mental status, and autonomic instability. This …

Most of the toxic agents (the so-called poisons) cause central and/or peripheral neurotoxic
effects. In the diagnostic process of many of the acute neurological syndromes, it is …

Аннотация Обоснование: злокачественный нейролептический синдром (ЗНС) является
грозным осложнением терапии нейролептиками ихарактеризуется высокой …

Around 10 million people worldwide have Parkinson's and in the UK the estimated figure is
153 000. The condition is characterised by motor symptoms including tremors, stiffness …

Neuroleptic malignant syndrome (NMS) is a rare, potentially lethal syndrome known to be
related to the initiation of dopamine antagonist medications or rapid withdrawal of …

Neuroleptic malignant syndrome (NMS) is described in the medical literature but rarely seen
among acutely ill trauma patients. A 44-year-old man with burns to the hands and back after …

Cyclophosphamide (CP) is a distinguished anticancer and immune subduing medicament.
Conversely, regardless of its pervasive proven use, it retains limitations of neurotoxicity …

Sažetak Hitna psihijatrija obuhvaća kliničku primjenu psihijatrije u hitnim stanjima. U takvim
situacijama, određeni psihofarmaci mogu izazvati psihijatrijske sindrome koji zahtijevaju …